Press Releases Latest Mar 14, 2023 Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model Press Releases Year None20232022202120202019201820172016201520142013 Dec 08, 2020 Theratechnologies Announces New Findings For Its Lead Investigational Compound TH1902 For The Treatment Of Several Additional Cancers Nov 23, 2020 Theratechnologies To Present At The Piper Sandler Virtual Healthcare Conference Nov 16, 2020 Theratechnologies Announces Data From Oral Presentation At AASLD Showing How Tesamorelin Can Reduce Fibrosis And NASH Nov 06, 2020 Theratechnologies Announces That Data On The Mechanism Of Effect Of Tesamorelin In NAFLD Will Be Presented At The Liver Meeting® 2020 Nov 03, 2020 Theratechnologies Announces Departure Of Chief Commercial Officer Oct 22, 2020 Theratechnologies To Present At Upcoming Investor Conferences On October 29 And November 10, 2020 Oct 16, 2020 Theratechnologies Appoints Two New Board Members Oct 15, 2020 Theratechnologies Announces Financial Results For The Third Quarter Of Fiscal 2020 Oct 13, 2020 Theratechnologies Confirms Issuance Of U.S. Patent Covering The Use Of Tesamorelin In The Treatment Of Individuals Suffering From NAFLD/NASH Oct 05, 2020 Theratechnologies To Announce Financial Results For Third Quarter 2020 First page « Previous page ‹ … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page › Last page » Displaying 81 - 90 of 305
Mar 14, 2023 Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model
Dec 08, 2020 Theratechnologies Announces New Findings For Its Lead Investigational Compound TH1902 For The Treatment Of Several Additional Cancers
Nov 16, 2020 Theratechnologies Announces Data From Oral Presentation At AASLD Showing How Tesamorelin Can Reduce Fibrosis And NASH
Nov 06, 2020 Theratechnologies Announces That Data On The Mechanism Of Effect Of Tesamorelin In NAFLD Will Be Presented At The Liver Meeting® 2020
Oct 22, 2020 Theratechnologies To Present At Upcoming Investor Conferences On October 29 And November 10, 2020
Oct 13, 2020 Theratechnologies Confirms Issuance Of U.S. Patent Covering The Use Of Tesamorelin In The Treatment Of Individuals Suffering From NAFLD/NASH
